3-{3-[4-Methyl-5-(2-morpholin-4-yl-pyridin-4-yl)-thiazol-2-yl]-ureido}-propionic acid ethyl ester → 3-[3-(4-Methyl-5-pyridin-4-yl-thiazol-2-yl)-ureido]-propionic acid ethyl ester

HRID 1951183

Reaktionsgleichung

Reaktionsgleichung von HRID 1951183
[CH2:1]([O:3][C:4](=[O:29])[CH2:5][CH2:6][NH:7][C:8]([NH:10][C:11]1[S:12][C:13]([C:17]2[CH:22]=[CH:21][N:20]=[C:19](N3CCOCC3)[CH:18]=2)=[C:14]([CH3:16])[N:15]=1)=[O:9])[CH3:2].C(OC(=O)CNC(NC1SC(C2C=CN=CC=2)=C(C)N=1)=O)C>>[CH2:1]([O:3][C:4](=[O:29])[CH2:5][CH2:6][NH:7][C:8]([NH:10][C:11]1[S:12][C:13]([C:17]2[CH:18]=[CH:19][N:20]=[CH:21][CH:22]=2)=[C:14]([CH3:16])[N:15]=1)=[O:9])[CH3:2]

Komponenten

3

Edukt 2

HCID 112471293-{3-[4-Methyl-5-(2-morpholin-4-yl-pyridin-4-yl)-thiazol-2-yl]-ureido}-propionic acid ethyl esterHCID 11415948HCID 11415948, Verbindung

Produkt 1

HCID 114163633-[3-(4-Methyl-5-pyridin-4-yl-thiazol-2-yl)-ureido]-propionic acid ethyl ester

Versuchsvorschrift

This compound is prepared by an analogous procedure to 3-{3-[4-Methyl-5-(2-morpholin-4-yl-pyridin-4-yl)-thiazol-2-yl]-ureido}-propionic acid ethyl ester (Example 14) by replacing 4-Methyl-5-(2-morpholin-4-yl-pyridin-4-yl)-thiazol-2-ylamine hydrobromide (13b) with 4-methyl-5-pyridin-4-yl-thiazol-2-ylamine (see Example 16 for reference).

Quellen und Nachweise

ORD-Eintrag
ord-db1c140c7b3346bd82afd42fa84d251a
Quelldatensatz
uspto-grants-2013_03
Patentnummer
US08404684B2

Verknüpfte Notizen

Wird geladen…